COMMUNIQUÉS West-GlobeNewswire

Tauriga Sciences, Inc. Fully Satisfies its Financial Obligations Pursuant to Tauri-Gum Manufacturing Agreement
28/01/2019
Company Has Paid in Full for Entire Initial Production Run of its CBD Infused Chewing Gum; Branded as Tauri-Gum TM NEW YORK, NY, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG [...]
Wellness Matrix Group Files Required Disclosures with OTC Markets
28/01/2019
LOS ANGELES, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Wellness Matrix Group, Inc. (OTC PINK: WMGR), which is developing technologically advanced virtual reality and artificial intelligence utilizing healthcare platform models [...]
Nicotine dependence is an increasing problem
28/01/2019
Press release 28 th of January 2019 Nicotine dependence is an increasing health problem even if smoking itself shows a declining trend. Nicotine-containing products frequently remain “on” even for years after smoking [...]
Conatus Pharmaceuticals Announces Publications Expanding on Previously Reported Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials
28/01/2019
SAN DIEGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced publications expanding on previously reported results from three of the company’s completed Phase 2 clinical trials [...]
VitalHub Announces licensing of TREAT and B Care solutions to the Government of Yukon to improve the management and treatment of Mental Wellness and Substance Use across the Territory
28/01/2019
TORONTO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce the sale of both the TREAT and B Care solutions to the Government of Yukon Health and Social Services (H& [...]
Helix BioPharma Corp. Extends Annual Meeting Date
28/01/2019
RICHMOND HILL, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, [...]
Medtronic Announces U.S. Commercial Launch of Mazor X Stealth(TM) Edition for Robotic-Assisted Spine Surgery
28/01/2019
First U.S. Patients Treated Using Mazor X Stealth(TM) Edition at Norton Healthcare and Reston Hospital Center DUBLIN - January 28, 2019 - Medtronic plc (NYSE:MDT) today announced the first U.S. patients treated with the [...]
XORTX to Present at NobleConXV Noble Capital Markets’ 15th Annual Investor Conference
28/01/2019
CALGARY, Alberta, Jan. 28, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Horizon Discovery and Rutgers University form exclusive partnership to develop next generation novel gene editing technology
28/01/2019
Horizon Discovery Group plc Horizon Discovery and Rutgers University form exclusive partnership to develop next generation novel gene editing technology Horizon will work with Rutgers University to develop and [...]
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
28/01/2019
FT. MYERS, Fla., Jan. 28, 2019 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of cancer-focused genetic testing services, announced today that it plans to release its fourth quarter and fiscal [...]
Protalix BioTherapeutics to Present Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 15th Annual WORLDSymposium™ 2019
28/01/2019
~Oral presentation to include pharmacokinetic and anti-drug antibody data for first 15 patients enrolled~ CARMIEL, Israel, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX [...]
EyePoint Pharmaceuticals Appoints David Guyer, M.D., to Board of Directors
28/01/2019
– Dr. Guyer is a Successful Ophthalmology Entrepreneur with Deep Business and Clinical Experience in Advancing Treatments for Ocular Diseases - WATERTOWN, Mass., Jan. 28, 2019 (GLOBE NEWSWIRE) -- EyePoint [...]
CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer
28/01/2019
Drug development veteran to lead CureVac’s global product development efforts as the company looks to advance its pipeline of mRNA-based products TÜBINGEN, Germany and BOSTON, Jan. 28, 2019 (GLOBE NEWSWIRE) -- CureVac [...]
Trevena Announces Receipt of Type A Meeting Minutes and Provides Regulatory Update for Oliceridine
28/01/2019
– Company announces initial path forward on oliceridine NDA – – Company to host conference call on Monday, January 28 at 8:30 a.m. ET – CHESTERBROOK, Pa., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) [...]
Emerald Health sees Expansion of Pure Sunfarms’ Cannabis Cultivation License to 825,000 Square Feet
28/01/2019
1.1 million square foot Pure Sunfarms facility on track to reach full production capacity in first half 2019 VICTORIA, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or [...]
Cerecor Announces U.S. Headquarters Move Into Pharmaceutical Corridor of Rockville, Maryland
28/01/2019
ROCKVILLE, Md., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments in rare and orphan diseases in [...]
Tetra Bio-Pharma Files Patent Application to Protect PPP001
28/01/2019
Tetra Natural Health’s Distribution Partner Expands Distribution Network for the Hemp Energy Drink ORLEANS, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or the “ Company ”) (TSX VENTURE: [...]
111, Inc. to Collaborate with Lilly in Creating New Solutions for Pharmaceutical Distribution
28/01/2019
SHANGHAI, China, Jan. 28, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform, today announced it has signed a strategic cooperation [...]
Evelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic Melanoma
28/01/2019
- Initial Clinical Data Anticipated in Second Half of 2020 - CAMBRIDGE, Mass., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a biotechnology company developing monoclonal microbials [...]

Pages